Dear Colleagues:

We are pleased to announce a release of a new cost-sharing brief, Medicaid Reimbursement for Quitline Pharmacy Products. This brief identifies current processes, barriers, and breakthroughs, and “ideal” processes that may be considered when state quitline funders and service providers seek Medicaid reimbursement for pharmacotherapy.

We hope you will find this cost-sharing brief useful in identifying opportunities within your state tobacco control program and applying some of the lessons learned from the participating states. Please look for a webinar on the topic to be announced shortly.

Warm regards,

NAQC Staff